Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
International Clinical Psychopharmacology|May 12, 2016
Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?Georgios Schoretsanitis, Ekkehard Haen, Christoph Hiemke, et al.
Therapeutic Drug Monitoring|September 26, 2012
Implementation of a cost-effective HPLC/UV approach for routine medical quantification of memantine in human serumEkkehard Haen, Ralf Koeber, Hans-Hermann Klünemann, et al.
Neurobiology of Aging|August 9, 2005
Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sampleBernd Ibach, Harald Binder, Margarethe Dragon, et al.
Journal of Clinical Psychopharmacology|November 6, 2019
Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Mental Well-Being in Schizophrenia: Results From the Randomized NeSSy TrialTanja Veselinović, Martin Scharpenberg, Martin Heinze, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 29, 2022
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysisNazar Kuzo, Ekkehard Haen, Dominic M Ho, et al.
The Journal of Clinical Psychiatry|May 21, 2020
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und PharmakopsychiatrieGeorgios Schoretsanitis, John M Kane, Christoph U Correll, et al.
Der Nervenarzt|November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Pharmacopsychiatry|July 2, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspectsXenia M Hart, Gerhard Gründer, Christoph Hiemke, et al.
Pageof 8